Osteoarthritis year 2012 in review: Genetics and genomics

Osteoarthritis and Cartilage

Volumn 20, Issue 12, 2012, Pages 1470-1476

  van Meurs, J B J ^a,b   Uitterlinden, A G ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Netherlands Genomics Initiative   (Netherlands)

Author keywords

DNA variants; Genetics; Genomics; Osteoarthritis

Indexed keywords

PURINERGIC P2X7 RECEPTOR; SMAD3 PROTEIN; VANILLOID RECEPTOR 4;

ARTHRALGIA; BONE DEVELOPMENT; CPG ISLAND; DNA METHYLATION; EXOME; GENE EXPRESSION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC DISORDER; GENETIC RISK; GENOMICS; HISTONE MODIFICATION; HUMAN; INFLAMMATORY PAIN; NEXT GENERATION SEQUENCING; ONSET AGE; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; SAMPLE SIZE; TRANSCRIPTOMICS;

GENETIC TESTING; GENOMICS; HUMANS; OSTEOARTHRITIS;

EID: 84867891001     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.08.007     Document Type: Review

References (46)

1. Warman M.L., Cormier-Daire V., Hall C., Krakow D., Lacman R., LeMerrer M., et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A 2011, 155A:943-968.
2. Cormier-Daire V. Spondylo-epi-metaphyseal dysplasia. Best Pract Res Clin Rheumatol 2008, 22:33-44.
3. van de Laar I.M.B.H., Oldenburg R.A., Pals G., Roos-Hesselink J.W., de Graaf B.M., Verhagen J.M.A., et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 2011, 43:121-126.
4. Lamande S.R., Yuan Y., Gresshoff I.L., Rowley L., Bellupccio D., Kaluarachchi K., et al. Mutations in TRPV4 cause an inherited arthropathy of hands and feet. Nat Genet 2011, 43:1142-1146.
5. de Pontual L., Yao E., Callier P., Faivre L., Drouin V., Cariou S., et al. Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nat Genet 2011, 43:1026-1030.
6. Valdes A.M., Spector T.D., Tamm A., Kisand K., Doherty S.A., Dennison E.M., et al. Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum 2010, 62:2347-2352.
7. Evangelou E., Chapman K., Meulenbelt I., Karassa F.B., Loughlin J., Carr A., et al. Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum 2009, 60:1710-1721.
8. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., Song G.G. Osteoarthritis susceptibility loci defined by genome scan meta-analysis. Rheumatol Int 2006, 26:959-963.
9. Valdes A.M., Spector T.D. Genetic epidemiology of hip and knee osteoarthritis. Nat Rev Rheumatol Jan 2011, 7(1):23-32.
10. Thomas J.T., Kilpatrick M.W., Lin K., Erlacher L., Lembessis P., Costa T., et al. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 1997, 17:58-64.
11. Polinkovsky A., Robin N.H., Thomas J.T., Irons M., Lynn A., Goodman F.R., et al. Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat Genet 1997, 17:18-19.
12. Miyamoto Y., Mabuchi A., Shi D., Kubo T., Takatori Y., Saito S., et al. A functional polymorphism in the 5' UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 2007, 39:529-533.
13. Vaes R.B., Rivadeneira F., Kerkhof J.M., Hofman A., Pols H.A., Uitterlinden A.G., et al. Genetic variation in the GDF5 region is associated with osteoarthritis, height, hip axis length and fracture risk: the Rotterdam study. Ann Rheum Dis 2009, 68:1754-1760.
14. Valdes A.M., Evangelou E., Kerkhof H.J., Tamm A., Doherty S.A., Kisand K., et al. The GDF5 rs143383 polymorphism is associated with osteoarthritis of the knee with genome-wide statistical significance. Ann Rheum Dis 2011, 70:873-875.
15. Manning A.K., Hivert M.F., Scott R.A., Grimsby J.L., Bouatia-Naji N., Chen H., et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012, 44:659-669.
16. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2011, 43:339-344. Coronary Artery Disease (C4D) Genetics Consortium.
17. Schunkert H., Konig I.R., Kathiresan S., Reilly M.P., Assimes T.L., Holm H., et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011, 43:333-338.
18. Lango Allen H., Estrada K., Lettre G., Berndt S.I., Weedon M.N., Rivadeneira F., et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010, 467:832-838.
19. arcOGEN Consortium and arcOGEN Collaborators Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet 2012 July 2, [epub ahead of print].
20. Ioannidis J.P., Thomas G., Daly M.J. Validating, augmenting and refining genome-wide association signals. Nat Rev Genet 2009, 10:318-329.
21. Kerkhof H.J., Meulenbelt I., Akune T., Arden N.K., Aromaa A., Bierma-Zeinstra S.M., et al. Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage 2011, 19:254-264.
22. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003, 160:636-645.
23. Blangero J., Williams J.T., Almasy L. Novel family-based approaches to genetic risk in thrombosis. J Thromb Haemost 2003, 1:1391-1397.
24. Castano Betancourt M.C., Cailotto F., Kerkhof H.J., Cornelis F.M., Doherty S.A., Hart D.J., et al. Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc Natl Acad Sci USA 2012, 109:8218-8223.
25. Sorge R.E., Trang T., Dorfman R., Smith S.B., Beggs S., Ritchie J., et al. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med 2012, 18:595-599.
26. Malfait A.M., Seymour A.B., Gao F., Tortorella M.D., Le Graverand-Gastineau M.P., Wood L.S., et al. A role for PACE4 in osteoarthritis pain: evidence from human genetic association and null mutant phenotype. Ann Rheum Dis 2012, 71:1042-1048.
27. Egli R.J., Southam L., Wilkins J.M., Lorenzen I., Pombo-Suarez M., Gonzalez A., et al. Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheum 2009, 60:2055-2064.
28. Bos S.D., Bovee J.V., Duijnisveld B.J., Raine E.V., van Dalen W.J., Ramos Y.F., et al. Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissues. Ann Rheum Dis 2012, 71:1254-1258.
29. Kerkhof H.J., Lories R.J., Meulenbelt I., Jonsdottor I., Valdes A.M., Arp P., et al. A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum 2010, 62:499-510.
30. Raine E.V., Wreglesworth N., Dodd A.W., Reynard L.N., Loughlin J. Gene expression analysis reveals HBP1 as a key target for the osteoarthritis susceptibility locus that maps to chromosome 7q22. Ann Rheum Dis 2012 Jul 6, [Epub ahead of print].
31. Cailotto F., Luyten F.P., Lories R.J. Cog5 inhibition induces glycosylation defects affecting chondrogenesis and interfering with Wnt, but not Bmp signaling. Osteoarthritis Cartilage Apr 2012, 20:S142-S143.
32. Bamshad M.J., Ng S.B., Bigham A.W., Tabor H.K., Emond M.J., Nickerson D.A., et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 2011, 12:745-755.
33. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 2010, 465:721-727.
34. Feil R., Fraga M.F. Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet 2011, 13:97-109.
35. Reynard L.N., Bui C., Canty-Laird E.G., Young D.A., Loughlin J. Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. Hum Mol Genet 2011, 20:3450-3460.
36. den Hollander W., Bos S.D., Ramos Y.F., Lakenberg N., van der Breggen R., Duijnisveld B.J., et al. Cpg sites of osteoarthritis susceptibility gene Dio2 are differentially methylated in arthritic compared to preserved cartilage. Osteoarthritis Cartilage 2012, 20:S196.
37. Fernandez-Tajes J., Fernandez-Moreno M., Tamayo-Novas M., Mosquera-Rey A., Oreira-Villar N., Fernandez-Moreno M., et al. The analysis of the genome-wide DNA methylation profile of human articular chondrocytes reveals different forms of OA. Osteoarthritis Cartilage 2012, 20:S42.
38. Attur M., Belitskaya-Levy I., Oh C., Krasnokutsky S., Greenberg J., Samuels J., et al. Increased interleukin-1beta gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Arthritis Rheum 2011, 63:1908-1917.
39. Xu Y., Barter M.J., Swan D.C., Rankin K.S., Rowan A.D., Santibanez-Koref M., et al. Comparison of osteoarthritis and normal hip cartilage transcriptomes using Rna-Seq reveals new candidate gene targets and associated pathways. Osteoarthritis Cartilage 2012, 20:S43.
40. Husar-Memmer E., Ekici A., Al Kaissi A., Sticht H., Mager B., Schett G., et al. Premature osteoarthritis as presenting sign of type II collagenopathy: a case report and literature review. Semin Arthritis Rheum June 2012, 2012. [epub ahead of print].
41. Gleghorn L., Ramesar R., Beighton P., Wallis G. A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis. Am J Hum Genet 2005, 77:484-490.
42. Jackson G.C., Mittaz-Crettol L., Taylor J.A., Mortier G.R., Spranger J., Zabel B., et al. Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution. Hum Mutat 2012, 33:144-157.
43. Meulenbelt I., Min J.L., Bos S., Riyazi N., Houwing-Duistermaat J.J., van der Wijk H.J., et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet 2008, 17:1867-1875.
44. Day-Williams A.G., Southam L., Panoutsopoulou K., Rayner N.W., Esko T., Estrada K., et al. A variant in MCF2L is associated with osteoarthritis. Am J Hum Genet 2011, 89:446-450.
45. Miyamoto Y., Shi D., Nakajima M., Ozaki K., Sudo A., Kotani A., et al. Common variants in DVWA on chromosome 3p24.3 are associated with susceptibility to knee osteoarthritis. Nat Genet 2008, 40:994-998.
46. Nakajima M., Takahashi A., Kou I., Rodriguez-Fontenla C., Gomez-Reino J.J., Furuichi T., et al. New sequence variants in HLA class II/III region associated with susceptibility to knee osteoarthritis identified by genome-wide association study. PLoS One 2010, 5:e9723.